CD8A and neoplasm: Infiltration of CD45RO+CD3+ T cells (as well as CD8+ T cells and GzmB+ cells) into CRC lesions correlates with highly improved prognosis, suggesting that T cells have strong therapeutic potential for the treatment of this tumor [95].